Profhilo Body 3.2%
Profhilo® Body is an injectable hyaluronic acid treatment specifically developed to address skin laxity and loss of firmness across the body. Manufactured by IBSA, it uses the patented NAHYCO® Hybrid Technology to combine high and low molecular weight hyaluronic acid into a stabilised hybrid cooperative complex, without conventional chemical cross-linking agents.
Profhilo Body works within the dermal tissue to support hydration, elasticity and overall skin quality. It is particularly suited to areas where the skin has become loose, less elastic or affected by visible signs of ageing.
Key Benefits of Profhilo® Body
- Helps improve the appearance of loose and lax skin
- Supports skin hydration and moisture retention
- Helps improve firmness and elasticity
- Supports overall skin quality and tissue remodelling
- Helps improve the appearance of fine lines associated with skin ageing
- Can help redefine the appearance of body contours
- Suitable for targeted body skin-rejuvenation protocols
- Provides a non-surgical approach to improving skin quality
Advanced Hyaluronic Acid Formulation
Profhilo Body contains 96mg of hyaluronic acid in a 3ml pre-filled syringe, consisting of:
- 48mg high molecular weight hyaluronic acid (H-HA)
- 48mg low molecular weight hyaluronic acid (L-HA)
The formulation is supplied in a buffered physiological solution and is manufactured using IBSA’s NAHYCO® technology.
Treatment Areas
Profhilo Body is designed for treatment of skin laxity on the body. Areas commonly associated with the product include:
- Abdomen
- Inner arms
- Knees
- Décolletage
- Other areas affected by body skin laxity
The product’s manufacturer information also identifies its use in dermal tissue repair processes associated with acne scarring. Treatment areas and suitability should be determined by an appropriately qualified practitioner following an individual assessment.
How Profhilo® Body Works
The combination of high and low molecular weight hyaluronic acid is designed to provide a bioremodelling effect within the dermal tissue. Rather than functioning as a conventional volumising dermal filler, Profhilo Body is focused on improving skin quality, hydration, firmness and elasticity.
The treatment delivers hyaluronic acid directly into the dermal layer, supporting the extracellular matrix and the physiological environment of the skin.
Treatment Protocol
The manufacturer’s product information describes an initial course of two treatment sessions approximately 30 days apart, with maintenance treatment considered according to the individual’s skin condition and degree of ageing.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Profhilo® Body |
| Manufacturer | IBSA Farmaceutici Italia S.r.l. |
| Product Type | Injectable Hyaluronic Acid Treatment |
| Technology | NAHYCO® Hybrid Technology |
| Syringe Volume | 3ml |
| Total Hyaluronic Acid | 96mg |
| High Molecular Weight HA | 48mg |
| Low Molecular Weight HA | 48mg |
| HA Concentration | 3.2% |
| Administration | Intradermal |
| Primary Indication | Body skin laxity remodelling |
| Treatment Areas | Body areas affected by skin laxity |
| Packaging | 1 × 3ml pre-filled syringe |
For professional use only. Profhilo® Body should be administered by appropriately qualified and trained practitioners in accordance with the manufacturer’s current Instructions for Use and applicable UK requirements.



